India pharma inventory strains

- India’s pharma sector is holding about two months of active pharmaceutical ingredient (API) inventory and four to five months of finished formulation stock, amid feedstock disruptions. - The social report named methanol supply issues and price spikes in paracetamol and azithromycin APIs as specific pressures. - API feedstock shocks and input price jumps can ripple into lead times and cost for finished lab reagents and related consumables. (x.com)